0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Ideas and Opinions |

Lipitor Goes Generic: Business as Usual or More Big Business?

Lisa Gill; John Santa, MD, MPH; Doris L. Peter, PhD; and Joel Keehn, MS
[+] Article and Author Information

From Consumer Reports, Yonkers, New York.

Potential Conflicts of Interest: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-0361.

Requests for Single Reprints: John Santa, MD, MPH, Consumer Reports, 101 Truman Avenue, Yonkers, NY 10703; e-mail, HealthImpact@cr.consumer.org.

Current Author Addresses: Ms. Gill, Drs. Santa and Peter, and Mr. Keehn: Consumer Reports, 101 Truman Avenue, Yonkers, NY 10703.

Author Contributions: Conception and design: L. Gill, J. Santa, J. Keehn.

Analysis and interpretation of the data: L. Gill, J. Santa, J. Keehn.

Drafting of the article: L. Gill, J. Santa, J. Keehn.

Critical revision of the article for important intellectual content: L. Gill, J. Santa, D.L. Peter, J. Keehn.

Final approval of the article: L. Gill, J. Santa, D.L. Peter.

Obtaining of funding: J. Santa, D.L. Peter.

Administrative, technical, or logistic support: L. Gill, J. Santa.

Collection and assembly of data: L. Gill, J. Santa.


Ann Intern Med. 2012;156(12):892-893. doi:10.7326/0003-4819-156-12-201206190-00420
Text Size: A A A

The lipid-lowering drug atorvastatin converted from brand only (Lipitor) to generic in late 2011. Certain insurers have reportedly instructed some pharmacies to fill prescriptions with Lipitor, even if patients present with a prescription for generic atorvastatin. This commentary discusses Lipitor versus the generic atorvastatin and the unusual pricing situation and provides advice for physicians whose patients have been taking Lipitor.

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Updates to Lipitor pricing and availability
Posted on May 14, 2012
Lisa, Gill, Editor, John Santa, MD, Doris Peter, PhD, Joel Keehn, MS
Consumer Reports
Conflict of Interest: None Declared

Since this article first appeared on annals.org in March 2012, new developments have occurred. In May 2012, Pfizer reported that they stopped making deals with health plans to offer Lipitor at the lowest-price copay tiers. Pfizer also made two changes to their $4 Lipitor co-pay program: It will now pay up to $75 of the cost of a patient's copay for Lipitor (up from the $50 previously offered) and the program will expire in December 2014 instead of at the end of 2012. In addition, Medicare.gov has added atorvastatin to the list of medications that patients can add to their search of Part D plans.

Conflict of Interest:

None declared

Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)